US to start using Bavarian vaccine stockpile

In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.

Photo: Lukas Barth/Reuters/Ritzau Scanpix

American residents who have been in contact with people infected with monkeypox will be offered a protective shot with Bavarian Nordic’s vaccine, Jynneos, the US Centers for Disease Control and Prevention (CDC) reports according to Reuters.

The US currently has a stockpile of over 1,000 doses of the vaccine, which has been approved for smallpox and monkeypox since 2019 in the US. Following the monkeypox outbreak, the CDC is expecting to increase its level of preparedness in the near future.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs